Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.61M Sell
37,830
-976
-3% -$78.7K 0.01% 474
2026
Q1
$3.34M Buy
38,806
+4,210
+12% +$396K 0.02% 446
2025
Q4
$3.27M Sell
34,596
-100,248
-74% -$10.3M 0.02% 434
2025
Q3
$14.5M Sell
134,844
-30,832
-19% -$3.37M 0.08% 218
2025
Q2
$18M Sell
165,676
-72,415
-30% -$6.97M 0.1% 185
2025
Q1
$19.7M Buy
238,091
+4,096
+2% +$328K 0.12% 161
2024
Q4
$18.3M Sell
233,995
-71,457
-23% -$5.93M 0.11% 178
2024
Q3
$24.6M Buy
305,452
+101,047
+49% +$8.36M 0.14% 149
2024
Q2
$17.1M Buy
204,405
+144,948
+244% +$11.8M 0.1% 196
2024
Q1
$4.94M Buy
59,457
+22,478
+61% +$1.85M 0.03% 343
2023
Q4
$2.98M Buy
+36,979
New +$2.56M 0.02% 419
2022
Q4
Sell
-194,751
Closed -$8.59M 889
2022
Q3
$8.59M Buy
+194,751
New +$9.17M 0.06% 299

Other funds holding STN

Candriam SCA's STN Position: Q2 2026 in Review

Candriam SCA reduced its Stantec (STN) stake by 2.5% in Q2 2026, selling an estimated $78.7K and leaving 37,830 shares worth $2.61M. The position accounts for 0.01% of the portfolio, ranked #474.

Candriam SCA first reported a position in STN in Q3 2022 and has held it in 12 quarters since. The position peaked at $24.6M in Q3 2024. 291 funds tracked by Wall St. Rank hold STN as of Q2 2026.

  • Candriam SCA held 37,830 shares of Stantec worth $2.61M as of Q2 2026.
  • Candriam SCA sold 976 Stantec shares in Q2 2026, an estimated $78.7K.
  • Stantec made up 0.01% of Candriam SCA's portfolio in Q2 2026, its #474 holding.
  • Candriam SCA first reported a position in Stantec in Q3 2022 and has held it in 12 quarters since.
  • Candriam SCA's Stantec position peaked at $24.6M in Q3 2024.
  • 291 funds tracked by Wall St. Rank held Stantec as of Q2 2026.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.